Pages that link to "Q35608640"
Jump to navigation
Jump to search
The following pages link to Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles (Q35608640):
Displaying 50 items.
- Apolipoprotein C3 SstI polymorphism and triglyceride levels in Asian Indians (Q21283798) (← links)
- Mitogen-activated protein kinase regulates transcription of the ApoCIII gene. Involvement of the orphan nuclear receptor HNF4 (Q22010768) (← links)
- Transcriptional regulation of apolipoprotein C-III gene expression by the orphan nuclear receptor RORalpha (Q24290442) (← links)
- Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5 (Q24294997) (← links)
- Apolipoprotein E enrichment of immuno-separated chylomicron and chylomicron remnants following saturated fatty acids (Q24300786) (← links)
- Effects of apoA-V on HDL and VLDL metabolism in APOC3 transgenic mice (Q24302828) (← links)
- Lysophosphatidylcholine acyltransferase 3 knockdown-mediated liver lysophosphatidylcholine accumulation promotes very low density lipoprotein production by enhancing microsomal triglyceride transfer protein expression (Q24314933) (← links)
- Apolipoprotein C-III: understanding an emerging cardiovascular risk factor (Q24318657) (← links)
- Proteomic analysis of human very low-density lipoprotein by two-dimensional gel electrophoresis and MALDI-TOF/TOF (Q24323213) (← links)
- An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3' untranslated region polymorphisms (Q24562942) (← links)
- Common variants at 30 loci contribute to polygenic dyslipidemia (Q24598765) (← links)
- Metabolism of very-low-density lipoprotein and low-density lipoprotein containing apolipoprotein C-III and not other small apolipoproteins (Q24651503) (← links)
- Associations among race/ethnicity, ApoC-III genotypes, and lipids in HIV-1-infected individuals on antiretroviral therapy (Q25255216) (← links)
- Apolipoprotein A-V gene therapy for disease prevention / treatment:a critical analysis (Q26775009) (← links)
- The risk of cardiovascular events with increased apolipoprotein CIII: A systematic review and meta-analysis (Q26801304) (← links)
- The crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemia (Q26864682) (← links)
- DNA sequence variation in human apolipoprotein C4 gene and its effect on plasma lipid profile (Q28139102) (← links)
- Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression (Q28191058) (← links)
- Increased cholesterol biosynthesis and hypercholesterolemia in mice overexpressing squalene synthase in the liver (Q28243492) (← links)
- Expression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditions (Q28252652) (← links)
- Functional analysis of the missense APOC3 mutation Ala23Thr associated with human hypotriglyceridemia (Q28271254) (← links)
- Genomic interval engineering of mice identifies a novel modulator of triglyceride production (Q28504607) (← links)
- Mice lacking ANGPTL8 (Betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis (Q28504875) (← links)
- Apoprotein C-III deficiency markedly stimulates triglyceride secretion in vivo: comparison with apoprotein E (Q28508473) (← links)
- Increased response to cholesterol feeding in apolipoprotein C1-deficient mice (Q28587768) (← links)
- Genetic determinants of plasma triglycerides: impact of rare and common mutations (Q28609419) (← links)
- A potent PPARalpha agonist stimulates mitochondrial fatty acid beta-oxidation in liver and skeletal muscle (Q31833512) (← links)
- The hypolipidemic action of bezafibrate therapy in hypertriglyceridemia is mediated by upregulation of lipoprotein lipase: no effects on VLDL substrate affinity to lipolysis or LDL receptor binding (Q31869703) (← links)
- Stimulation of the in vivo production of very low density lipoproteins by apolipoprotein E is independent of the presence of the low density lipoprotein receptor (Q33182404) (← links)
- Peroxisome proliferator-activated receptor-gamma regulates the expression and function of very-low-density lipoprotein receptor (Q33589043) (← links)
- Receptor-mediated mechanisms of lipoprotein remnant catabolism (Q33597635) (← links)
- Hypertriglyceridemia: changes in the plasma lipoproteins associated with an increased risk of cardiovascular disease (Q33652012) (← links)
- Effects of the PPARgamma agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus (Q33727061) (← links)
- Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism. Studies in transgenic mice (Q33900976) (← links)
- Liver proteomic response to hypertriglyceridemia in human-apolipoprotein C-III transgenic mice at cellular and mitochondrial compartment levels (Q33958622) (← links)
- Postprandial lipemia and coronary risk (Q34107425) (← links)
- The role of fibric acids in atherosclerosis (Q34109473) (← links)
- Orphan nuclear hormone receptor Rev-erbalpha regulates the human apolipoprotein CIII promoter (Q34129395) (← links)
- Overexpression of apolipoprotein CII causes hypertriglyceridemia in transgenic mice (Q34140679) (← links)
- Intestinal expression of human apolipoprotein A-IV in transgenic mice fails to influence dietary lipid absorption or feeding behavior (Q34141163) (← links)
- Complexities of plasma apolipoprotein C-III metabolism (Q34172178) (← links)
- Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates (Q34201490) (← links)
- Therapeutic considerations for postprandial dyslipidaemia (Q34285956) (← links)
- GLP-1 receptor activation inhibits VLDL production and reverses hepatic steatosis by decreasing hepatic lipogenesis in high-fat-fed APOE*3-Leiden mice (Q34469947) (← links)
- Plasma apolipoprotein C-III levels, triglycerides, and coronary artery calcification in type 2 diabetics (Q34480492) (← links)
- Apolipoprotein c3 gene polymorphisms are not a risk factor for developing non-alcoholic Fatty liver disease: a meta-analysis (Q34606616) (← links)
- Acute central neuropeptide Y administration increases food intake but does not affect hepatic very low-density lipoprotein (VLDL) production in mice (Q34608233) (← links)
- Dissociation between APOC3 variants, hepatic triglyceride content and insulin resistance (Q34674263) (← links)
- Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy (Q34829428) (← links)
- Evolving targets for lipid-modifying therapy (Q34880292) (← links)